Dana M Allswede1, Jean Addington1, Carrie E Bearden1, Kristin S Cadenhead1, Barbara A Cornblatt1, Daniel H Mathalon1, Thomas McGlashan1, Diana O Perkins1, Larry J Seidman1, Ming T Tsuang1, Elaine F Walker1, Scott W Woods1, Tyrone D Cannon1. 1. Department of Psychology (Allswede, Cannon) and Department of Psychiatry (McGlashan, Woods, Cannon), Yale University, New Haven, Conn.; Department of Psychiatry, University of Calgary, Calgary, Canada (Addington); Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, UCLA, Los Angeles (Bearden); Department of Psychiatry (Cadenhead, Tsuang) and Center for Behavioral Genomics (Tsuang), University of California, San Diego, La Jolla; Department of Psychiatry and Department of Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, N.Y. (Cornblatt); Department of Psychiatry, University of California, San Francisco, and San Francisco VA Medical Center, San Francisco (Mathalon); Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill (Perkins); Department of Psychiatry, Harvard Medical School, Boston (Seidman); and Department of Psychology, Emory University, Atlanta (Walker).
Abstract
OBJECTIVE: The authors sought to characterize differences in outcomes among help-seeking individuals at clinical high risk for psychosis by identifying covariant longitudinal patterns of symptoms and functioning. METHODS: Group-based multitrajectory modeling was applied to longitudinal ratings of four symptom domains (positive, negative, disorganized, general) and general functioning among clinical high-risk individuals in an initial discovery sample (N=422). An independent sample (N=133) was used to test replicability. RESULTS: Three trajectory groups were identified among clinical high-risk individuals in the discovery sample: group 1 (30%) exhibited substantial improvement across all domains, with half reaching positive outcomes for both functioning and positive symptoms; group 2 (49%) exhibited moderate impairments across domains, with approximately one-quarter meeting criteria for positive outcomes; the remaining participants (group 3; 22%) exhibited consistent levels of severe impairment across domains and did not experience positive outcomes. These trajectory groups and remission patterns were replicated in an independent sample. CONCLUSIONS: Replicable subgroups of help-seeking clinical high-risk cases can be ascertained based on distinctive profiles of change over time in symptoms and functioning. Within each of the three identified subgroups, similar patterns of change (i.e., rapid, moderate, or no improvement) were observed across the four symptom domains and functioning. This consistency of change over time across domains within each subgroup is a novel observation supporting the syndrome consistency of clinical high-risk symptoms and signs. The observed trajectory subgroups are suggestive of different degrees of need for clinical interventions, ranging from minimal or supportive for about one-third of cases to increasingly intensive among the remainder.
OBJECTIVE: The authors sought to characterize differences in outcomes among help-seeking individuals at clinical high risk for psychosis by identifying covariant longitudinal patterns of symptoms and functioning. METHODS: Group-based multitrajectory modeling was applied to longitudinal ratings of four symptom domains (positive, negative, disorganized, general) and general functioning among clinical high-risk individuals in an initial discovery sample (N=422). An independent sample (N=133) was used to test replicability. RESULTS: Three trajectory groups were identified among clinical high-risk individuals in the discovery sample: group 1 (30%) exhibited substantial improvement across all domains, with half reaching positive outcomes for both functioning and positive symptoms; group 2 (49%) exhibited moderate impairments across domains, with approximately one-quarter meeting criteria for positive outcomes; the remaining participants (group 3; 22%) exhibited consistent levels of severe impairment across domains and did not experience positive outcomes. These trajectory groups and remission patterns were replicated in an independent sample. CONCLUSIONS: Replicable subgroups of help-seeking clinical high-risk cases can be ascertained based on distinctive profiles of change over time in symptoms and functioning. Within each of the three identified subgroups, similar patterns of change (i.e., rapid, moderate, or no improvement) were observed across the four symptom domains and functioning. This consistency of change over time across domains within each subgroup is a novel observation supporting the syndrome consistency of clinical high-risk symptoms and signs. The observed trajectory subgroups are suggestive of different degrees of need for clinical interventions, ranging from minimal or supportive for about one-third of cases to increasingly intensive among the remainder.
Entities:
Keywords:
Clinical High Risk; Outcome Studies; Psychosis
Authors: Barnaby Nelson; G Paul Amminger; Hok Pan Yuen; Nicky Wallis; Melissa J Kerr; Lisa Dixon; Cameron Carter; Rachel Loewy; Tara A Niendam; Martha Shumway; Sarah Morris; Julie Blasioli; Patrick D McGorry Journal: Early Interv Psychiatry Date: 2017-07-18 Impact factor: 2.732
Authors: Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Barbara Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming Tsuang; Elaine F Walker; Scott W Woods; Robert Heinssen Journal: Schizophr Bull Date: 2007-01-25 Impact factor: 9.306
Authors: Tae Young Lee; Sung Nyun Kim; Christoph U Correll; Min Soo Byun; Euitae Kim; Joon Hwan Jang; Do-Hyung Kang; Je-Yeon Yun; Jun Soo Kwon Journal: Schizophr Res Date: 2014-05-09 Impact factor: 4.939
Authors: Jean Addington; Jacqueline Stowkowy; Lu Liu; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Carrie E Bearden; Daniel H Mathalon; Olga Santesteban-Echarri; Scott W Woods Journal: Psychol Med Date: 2018-09-04 Impact factor: 7.723
Authors: Jean Addington; Lu Liu; Lisa Buchy; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Daniel H Mathalon; Thomas H McGlashan Journal: J Nerv Ment Dis Date: 2015-05 Impact factor: 2.254
Authors: Tyrone D Cannon; Changhong Yu; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Barbara A Cornblatt; Robert Heinssen; Clark D Jeffries; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Michael W Kattan Journal: Am J Psychiatry Date: 2016-07-01 Impact factor: 18.112
Authors: Doreen M Olvet; Ricardo E Carrión; Andrea M Auther; Barbara A Cornblatt Journal: Early Interv Psychiatry Date: 2013-08-22 Impact factor: 2.732
Authors: Michelle A Worthington; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Barbara A Cornblatt; Matcheri Keshavan; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; William S Stone; Ming T Tsuang; Elaine F Walker; Scott W Woods; Tyrone D Cannon Journal: Schizophr Bull Date: 2022-03-01 Impact factor: 7.348
Authors: Scott W Woods; Carrie E Bearden; Fred W Sabb; William S Stone; John Torous; Barbara A Cornblatt; Diana O Perkins; Kristin S Cadenhead; Jean Addington; Albert R Powers; Daniel H Mathalon; Monica E Calkins; Daniel H Wolf; Cheryl M Corcoran; Leslie E Horton; Vijay A Mittal; Jason Schiffman; Lauren M Ellman; Gregory P Strauss; Daniel Mamah; Jimmy Choi; Godfrey D Pearlson; Jai L Shah; Paolo Fusar-Poli; Celso Arango; Jesus Perez; Nikolaos Koutsouleris; Jijun Wang; Jun Soo Kwon; Barbara C Walsh; Thomas H McGlashan; Steven E Hyman; Raquel E Gur; Tyrone D Cannon; John M Kane; Alan Anticevic Journal: Schizophr Res Date: 2020-05-10 Impact factor: 4.662
Authors: Frederike Schirmbeck; Nadine C van der Burg; Matthijs Blankers; Jentien M Vermeulen; Philip McGuire; Lucia R Valmaggia; Matthew J Kempton; Mark van der Gaag; Anita Riecher-Rössler; Rodrigo A Bressan; Neus Barrantes-Vidal; Barnaby Nelson; G Paul Amminger; Patrick McGorry; Christos Pantelis; Marie-Odile Krebs; Stephan Ruhrmann; Gabriele Sachs; Bart P F Rutten; Jim van Os; Merete Nordentoft; Birte Glenthøj; Paolo Fusar-Poli; Lieuwe de Haan Journal: Schizophr Bull Date: 2022-01-21 Impact factor: 9.306
Authors: Jean Addington; Megan S Farris; Lu Liu; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Carrie E Bearden; Daniel H Mathalon; William S Stone; Matcheri Keshevan; Scott W Woods Journal: Schizophr Res Date: 2020-10-29 Impact factor: 4.939